As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4879 Comments
1421 Likes
1
Shyquan
Power User
2 hours ago
Free US stock relative strength analysis and sector rotation tools to identify the strongest performing areas of the market. Our relative strength metrics help you focus on sectors and stocks with the most momentum.
👍 25
Reply
2
Ronrico
Senior Contributor
5 hours ago
Real-time US stock event calendar and catalyst tracking for understanding upcoming market-moving announcements and investment catalysts. Our event calendar helps you prepare for earnings releases, product launches, and other important dates that could impact stock prices. We provide event calendars, catalyst tracking, and announcement monitoring for comprehensive coverage. Never miss important events with our comprehensive event calendar and catalyst tracking tools for timely investment decisions.
👍 20
Reply
3
Verdell
Expert Member
1 day ago
This solution is so elegant.
👍 225
Reply
4
Litia
Power User
1 day ago
Makes understanding recent market developments much easier.
👍 45
Reply
5
Adidev
Consistent User
2 days ago
Ah, missed the opportunity. 😔
👍 147
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.